Literature DB >> 14522864

Diagnosis of prion diseases.

Eric Kübler1, Bruno Oesch, Alex J Raeber.   

Abstract

Prion diseases are usually diagnosed clinically and confirmed by post-mortem histopathological examination of brain tissue. The only reliable molecular marker for prion diseases is PrP(Sc), the pathological conformer of the prion protein that accumulates in the central nervous system and, to a lesser extent, in lymphoreticular tissues. For BSE, several commercial diagnostic kits based on the post-mortem immunochemical detection of PrP(Sc) in brain tissue are now available. These rapid screening tests have been used in active surveillance of BSE and have greatly improved the detection of infected cattle before their entry into the human food chain. At present, no diagnostic test exists for the detection of prion diseases in live animals or humans. New diagnostic techniques aimed at increasing sensitivity and specificity of PrP(Sc) detection in body fluids and at identifying novel surrogate markers are under development. In this report, we review the classical diagnostic methods as well as present and future tools for the diagnosis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522864     DOI: 10.1093/bmb/66.1.267

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  13 in total

1.  Generation of antisera to purified prions in lipid rafts.

Authors:  Robert Hnasko; Ana V Serban; George Carlson; Stanley B Prusiner; Larry H Stanker
Journal:  Prion       Date:  2010-04-09       Impact factor: 3.931

2.  Highly amyloidogenic two-chain peptide fragments are released upon partial digestion of insulin with pepsin.

Authors:  Marcin Piejko; Robert Dec; Viktoria Babenko; Agnieszka Hoang; Monika Szewczyk; Paweł Mak; Wojciech Dzwolak
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

3.  Evaluation of Western blotting methods using samples with or without sodium phosphotungstic acid precipitation for diagnosis of scrapie and chronic wasting disease.

Authors:  Hongsheng Huang; Jasmine Rendulich; Dan Stevenson; Katherine O'Rourke; Aru Balachandran
Journal:  Can J Vet Res       Date:  2005-07       Impact factor: 1.310

4.  Evaluation of the cumulative evidence for freedom from BSE in birth cohorts.

Authors:  Dankmar Böhning; Matthias Greiner
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

5.  Direct detection of disease associated prions in brain and lymphoid tissue using antibodies recognizing the extreme N terminus of PrPC.

Authors:  Geoff Barnard; Lee Hopkins; Sowmiya Moorthie; David Seilly; Paul Tonks; Reza Dabaghian; Jonathan Clewley; John Coward; Ian McConnell
Journal:  Prion       Date:  2007-04-15       Impact factor: 3.931

Review 6.  The expanding universe of prion diseases.

Authors:  Joel C Watts; Aru Balachandran; David Westaway
Journal:  PLoS Pathog       Date:  2006-03       Impact factor: 6.823

Review 7.  Prion Diagnosis: Application of Real-Time Quaking-Induced Conversion.

Authors:  Hae-Eun Kang; Youngwon Mo; Raihah Abd Rahim; Hye-Mi Lee; Chongsuk Ryou
Journal:  Biomed Res Int       Date:  2017-05-17       Impact factor: 3.411

8.  No H- and L-type cases in Belgium in cattle diagnosed with bovine spongiform encephalopathy (1999-2008) aging seven years and older.

Authors:  Alexandre Dobly; Jan Langeveld; Lucien van Keulen; Caroline Rodeghiero; Stéphanie Durand; Riet Geeroms; Patrick Van Muylem; Jessica De Sloovere; Emmanuel Vanopdenbosch; Stefan Roels
Journal:  BMC Vet Res       Date:  2010-05-21       Impact factor: 2.741

9.  In vitro prion protein conversion suggests risk of bighorn sheep (Ovis canadensis) to transmissible spongiform encephalopathies.

Authors:  Aaron R Morawski; Christina M Carlson; Haeyoon Chang; Christopher J Johnson
Journal:  BMC Vet Res       Date:  2013-08-09       Impact factor: 2.741

10.  Real-Time Quaking-Induced Conversion Analysis for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease in Korea.

Authors:  Jeong Ho Park; Yeong Gon Choi; Yun Jung Lee; Seok Joo Park; Hong Seok Choi; Kyung Chan Choi; Eun Kyoung Choi; Yong Sun Kim
Journal:  J Clin Neurol       Date:  2015-11-04       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.